Treatment of focal hand dystonia: current status.
Navnika GuptaSanjay PandeyPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)
and conclusion Currently, botulinum toxin has the best evidence for treatment of FHD, and 20-90% of patients experience symptomatic improvement. However, its benefit is often limited by the reduction of muscle tonus acting on the muscle spindle. Different surgical modalities that have been used to treat focal hand dystonia include lesional surgery, deep brain stimulation, and magnetic resonance-guided focused ultrasound thalamotomy. Recent studies exploring the role of behavioral techniques, sensorimotor training, and neuromodulation for the treatment of focal hand dystonia have reported good outcomes, but larger studies are required before implementing these interventions in practice.
Keyphrases
- deep brain stimulation
- magnetic resonance
- parkinson disease
- early onset
- primary care
- end stage renal disease
- healthcare
- obsessive compulsive disorder
- skeletal muscle
- current status
- minimally invasive
- type diabetes
- chronic kidney disease
- combination therapy
- acute coronary syndrome
- magnetic resonance imaging
- physical activity
- functional connectivity
- insulin resistance
- peritoneal dialysis
- coronary artery bypass
- weight loss
- contrast enhanced